// App-Quantinova.ai

4554 : Characterizing the outcomes of metastatic papillary renal cell carcinoma (papRCC).

Researchers

Presenter

  • J. Connor Wells

Principal Investigators

  • Anna Paola Fraccon

  • Felice Pasini

  • Georg A. Bjarnason

  • Jennifer J. Knox

  • Benoit Beuselinck

  • Sun Young Rha

  • Neeraj Agarwal

  • James Brugarolas

  • Jae-Lyun Lee

  • Sumanta K. Pal

  • Sandy Srinivas

  • D. Scott Ernst

  • Ulka N. Vaishampayan

  • Lori Wood

  • Robin Simpson

  • Guillermo de Velasco

  • Toni K. Choueiri

  • Daniel Yick Chin Heng

Medical Centers

  • Tom Baker Cancer Center, Calgary, AB, Canada

  • Department of Hematology, Aarhus University Hospital, Aarhus, Denmark

  • Medical Oncology, Casa di Cura Pederzoli, Peschiera Del Garda, Peschiera Del Garda (VR), Italy

  • Department of Oncology, S Maria della Misericordia Hospital, ULSS 18, Rovigo, Italy

  • Sunnybrook Odette Cancer Centre, Toronto, ON, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium

  • Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT

  • The University of Texas Southwestern Medical Center, Dallas, TX

  • City of Hope, Duarte, CA

  • Stanford Univeresity Medical Center, Stanford, CA

  • London Health Sciences Center, London, ON, Canada

  • Karmanos Cancer Institute, Detroit, MI

  • Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada

  • Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain

  • Dana-Farber/Brigham and Women's Cancer Center, Boston, MA

  • Tom Baker Cancer Center - University of Calgary, Calgary, AB, Canada

Locations

  • Canada

  • Italy

  • Spain

  • United States

  • Denmark

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Metastatic Renal Cell Cancer

  • Renal cell carcinoma

  • Clear cell renal carcinoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final